个人中心 - 老虎社区

骏马飞驰吧

IP属地：广东

帖子 · 412帖子 · 412
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 骏马飞驰吧骏马飞驰吧
  ·08-31 17:38
  $金螳螂(002081)$ 依然强势啊
  54 评论
  1
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-31 17:37
  $同源康医药-B(02410)$ 在肺癌脑转移这一临床难题上，TY-9591展现了明确的差异化优势，这是产品能够获批上市的根本原因，同源康正在经历盘捏重生
  165 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-27
  $平潭发展(000592)$ 今天涨停是几个意思？
  180 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-27
  $派格生物医药-B(02565)$ 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡
  150 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-21
  $派格生物医药-B(02565)$ 与全球GLP-1龙头相比估值处于历史最低梯队，即便考虑单产品风险，安全边际依然极厚，耐心持有者终将获得价值回报
  288 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-19
  $佑驾创新(02431)$ 空间还是有的细品
  445 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-19
  $真健康医疗-B(02697)$ 真健康医疗正从一家医疗机器人公司蜕变为涵盖"诊疗机器人+前沿器官生命支持系统"的全方位高端诊疗装备领军企业，定位升级意义深远
  634 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-18
  $同源康医药-B(02410)$ 8月17日开始震荡向上的迹象会在周二有所放大，幅度只能会更加之大
  460 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-13
  $亚泰集团(600881)$ 月线级别的压力位又到了
  609 评论
  点赞
  分享
  举报
- 骏马飞驰吧骏马飞驰吧
  ·08-13
  $派格生物医药-B(02565)$ 政策暖风直接利好港股18A创新药板块，派格作为H股全流通标的将间接受益于增量资金入场预期
  483 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4184380269673420","uuid":"4184380269673420","gmtCreate":1721277136144,"gmtModify":1750838066936,"name":"骏马飞驰吧","pinyin":"jmfcbjunmafeichiba","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":14,"headSize":13,"tweetSize":412,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":602653280146256,"gmtCreate":1788169110342,"gmtModify":1788169112514,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/002081\">$金螳螂(002081)$ </a> 依然强势啊","listText":"<a href=\"https://laohu8.com/S/002081\">$金螳螂(002081)$ </a> 依然强势啊","text":"$金螳螂(002081)$ 依然强势啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602653280146256","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602653062111272,"gmtCreate":1788169077577,"gmtModify":1788169080307,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 在肺癌脑转移这一临床难题上，TY-9591展现了明确的差异化优势，这是产品能够获批上市的根本原因，同源康正在经历盘捏重生","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 在肺癌脑转移这一临床难题上，TY-9591展现了明确的差异化优势，这是产品能够获批上市的根本原因，同源康正在经历盘捏重生","text":"$同源康医药-B(02410)$ 在肺癌脑转移这一临床难题上，TY-9591展现了明确的差异化优势，这是产品能够获批上市的根本原因，同源康正在经历盘捏重生","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602653062111272","isVote":1,"tweetType":1,"viewCount":165,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601272907051624,"gmtCreate":1787824788045,"gmtModify":1787824789974,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/000592\">$平潭发展(000592)$ </a> 今天涨停是几个意思？","listText":"<a href=\"https://laohu8.com/S/000592\">$平潭发展(000592)$ </a> 今天涨停是几个意思？","text":"$平潭发展(000592)$ 今天涨停是几个意思？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601272907051624","isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601242417890640,"gmtCreate":1787824745693,"gmtModify":1787824747904,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡","text":"$派格生物医药-B(02565)$ 经调整净亏损从 2024 年的 2.04 亿收窄至 2025 年的 0.98 亿，收窄幅度达 52%。收入增长 12 倍的同时亏损减半，经营杠杆效应显著。按照这个趋势，公司有望在 2026-2027 年实现盈亏平衡","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601242417890640","isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":599088529343480,"gmtCreate":1787287680249,"gmtModify":1787287682308,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 与全球GLP-1龙头相比估值处于历史最低梯队，即便考虑单产品风险，安全边际依然极厚，耐心持有者终将获得价值回报","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 与全球GLP-1龙头相比估值处于历史最低梯队，即便考虑单产品风险，安全边际依然极厚，耐心持有者终将获得价值回报","text":"$派格生物医药-B(02565)$ 与全球GLP-1龙头相比估值处于历史最低梯队，即便考虑单产品风险，安全边际依然极厚，耐心持有者终将获得价值回报","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/599088529343480","isVote":1,"tweetType":1,"viewCount":288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598393107886808,"gmtCreate":1787110288610,"gmtModify":1787110290414,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02431\">$佑驾创新(02431)$ </a> 空间还是有的 细品","listText":"<a href=\"https://laohu8.com/S/02431\">$佑驾创新(02431)$ </a> 空间还是有的 细品","text":"$佑驾创新(02431)$ 空间还是有的 细品","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598393107886808","isVote":1,"tweetType":1,"viewCount":445,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598393344377600,"gmtCreate":1787110253485,"gmtModify":1787110255668,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02697\">$真健康医疗-B(02697)$ </a> 真健康医疗正从一家医疗机器人公司蜕变为涵盖\"诊疗机器人+前沿器官生命支持系统\"的全方位高端诊疗装备领军企业，定位升级意义深远","listText":"<a href=\"https://laohu8.com/S/02697\">$真健康医疗-B(02697)$ </a> 真健康医疗正从一家医疗机器人公司蜕变为涵盖\"诊疗机器人+前沿器官生命支持系统\"的全方位高端诊疗装备领军企业，定位升级意义深远","text":"$真健康医疗-B(02697)$ 真健康医疗正从一家医疗机器人公司蜕变为涵盖\"诊疗机器人+前沿器官生命支持系统\"的全方位高端诊疗装备领军企业，定位升级意义深远","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598393344377600","isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":597884753146000,"gmtCreate":1786986101953,"gmtModify":1786986104075,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 8月17日开始震荡向上的迹象会在周二有所放大，幅度只能会更加之大","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 8月17日开始震荡向上的迹象会在周二有所放大，幅度只能会更加之大","text":"$同源康医药-B(02410)$ 8月17日开始震荡向上的迹象会在周二有所放大，幅度只能会更加之大","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/597884753146000","isVote":1,"tweetType":1,"viewCount":460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":596353778000968,"gmtCreate":1786612348539,"gmtModify":1786612350340,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/600881\">$亚泰集团(600881)$ </a> 月线级别的压力位又到了","listText":"<a href=\"https://laohu8.com/S/600881\">$亚泰集团(600881)$ </a> 月线级别的压力位又到了","text":"$亚泰集团(600881)$ 月线级别的压力位又到了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/596353778000968","isVote":1,"tweetType":1,"viewCount":609,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":596353651405752,"gmtCreate":1786612315785,"gmtModify":1786612318091,"author":{"id":"4184380269673420","authorId":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4184380269673420","idStr":"4184380269673420"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 政策暖风直接利好港股18A创新药板块，派格作为H股全流通标的将间接受益于增量资金入场预期","listText":"<a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 政策暖风直接利好港股18A创新药板块，派格作为H股全流通标的将间接受益于增量资金入场预期","text":"$派格生物医药-B(02565)$ 政策暖风直接利好港股18A创新药板块，派格作为H股全流通标的将间接受益于增量资金入场预期","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/596353651405752","isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}